AbbVie ABBV
NYSE ABBV
$249.54 +0.76 (+0.31%)
As of: Sep 9, 2026 · 12:01 PM EDT

AbbVie (ABBV) Dividend Coverage Ratio (2013 - 2026)

AbbVie's (ABBV) quarterly Dividend Coverage Ratio came in at 1.18 in Q2 2026, up 264.24% year-over-year from 0.32 in Q2 2025, and up 421.5% quarter-over-quarter from 0.23 in Q1 2026.

Analysis

AbbVie (ABBV) Dividend Coverage Ratio (2013 - 2026) Analysis & Trends

AbbVie (ABBV) has reported Dividend Coverage Ratio for 14 consecutive years, with 1.18 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Dividend Coverage Ratio rose 264.24% year-over-year to 1.18 in Q2 2026; TTM through Jun 2026 was 0.53, a 58.54% increase from a year earlier, with the FY2025 full-year figure at 0.36, down 6.59% from the prior year.
  • Dividend Coverage Ratio was 1.18 for Q2 2026 at AbbVie, up from 0.23 in the prior quarter.
  • Over five years, Dividend Coverage Ratio peaked at 1.78 in Q1 2022 and troughed at 0.04 in Q1 2023.
  • A 5-year average of 0.6 and a median of 0.5 in 2024 frame the typical range for Dividend Coverage Ratio.
  • Across the five-year window, Dividend Coverage Ratio slumped 102.66% in 2024 and jumped 7560.28% in 2025, its largest moves.
  • Over 5 years, Dividend Coverage Ratio stood at 0.99 in 2022, then tumbled by 68.19% to 0.31 in 2023, then tumbled by 102.66% to 0.01 in 2024, then jumped by 7560.28% to 0.62 in 2025, then surged by 88.91% to 1.18 in 2026.
  • The last three Dividend Coverage Ratio figures came in at 1.18 (Q2 2026), 0.23 (Q1 2026), and 0.62 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Cover (Qtr)
1 Johnson & Johnson 648.02 Bn 627.27 Bn 17.26 Bn 1.71
2 AbbVie 442.19 Bn 435.62 Bn 12.70 Bn 1.18
3 Merck 364.99 Bn 357.85 Bn 12.21 Bn -0.62
4 Novartis Ag 267.21 Bn 259.52 Bn 11.24 Bn 1.14
5 Pfizer 158.83 Bn 147.13 Bn 10.94 Bn -0.10
6 Sanofi 52.58 Bn 45.20 Bn 10.79 Bn 0.07
7 Revolution Medicines 44.25 Bn 44.25 Bn - -
8 Incyte 25.33 Bn 20.80 Bn 1.57 Bn -
9 United Therapeutics 21.28 Bn 18.62 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.52 Bn 15.13 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18
Mar 31, 2026 0.23
Dec 31, 2025 0.62
Sep 30, 2025 0.06
Jun 30, 2025 0.32
Mar 31, 2025 0.44
Dec 31, 2024 -0.01
Sep 30, 2024 0.57
Jun 30, 2024 0.50
Mar 31, 2024 0.49
Dec 31, 2023 0.31
Sep 30, 2023 0.68
Jun 30, 2023 0.77
Mar 31, 2023 -0.04
Dec 31, 2022 0.99
Sep 30, 2022 1.58
Jun 30, 2022 0.37
Mar 31, 2022 1.78
Dec 31, 2021 1.75
Sep 30, 2021 1.37